As of Apr 01
| +0.51 / +2.59%|
The 7 analysts offering 12-month price forecasts for Healthways Inc have a median target of 25.00, with a high estimate of 27.00 and a low estimate of 15.00. The median estimate represents a +23.70% increase from the last price of 20.21.
The current consensus among 9 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.